Designed to Cure

Speed time to market with higher quality novel therapeutics

Companies in pharmaceutical and biotechnology are challenged with the increasing need for open scientific innovation in the discovery stage and driving down costs while reducing time to market with higher quality novel therapeutics. Designed to Cure Industry Solution Experience enables scientists to work in partnership and share scientific results, aiding in the decision support to move the best candidates forward. Designed to Cure provides robust predictive analytics tools that leverage existing experimental results to rapidly optimize therapeutic efficacy and safety, and delivers analytics that provide an early prediction of potential downstream manufacturability issues, to guarantee rapid formulation of efficacious, stable therapeutics and speeds up time to market.

Designed to Cure enables therapeutic delivery, the prediction of critical design and manufacturability characteristics and delivers an integrated, comprehensive and rational drug development approach through virtual design, collaboration and knowledge driven innovation.

Download the Solution Flyer

2 minutes 4

Getting to Market Faster With Higher Quality Novel Therapeutics

Life Sciences laboratories face many problems in getting quality candidates to market. Whether it’s managing disconnected systems, coordinating external teams, identifying viable candidates, or costly failures, inefficiency reduces productivity to a crawl. This leads to increased upstream costs as well as time to market delays.

Designed to Cure delivers collaborative, knowledge-driven innovation and predictive analytics to address the cost and market challenges.

Benefits of Designed to Cure

Significantly improve collaboration for BioPharma

Improve collaboration using integrated systems that provide high quality, accessible scientific knowledge across the organization
Enhance decision-making for BioPharma

Enhance decision-making through real-time views across the lifecycle of therapeutics innovation
Accelerate Drug Design and Development for BioPharma

Accelerate drug design and development by combining in silico and physical experiments
Integrates Quality-by-Design Principles for BioPharma

Integrate Quality-by-Design principles to reduce the time to develop new drugs and increase the duration of market exclusivity
Reduce Time to Market and Accelerate Cost Savings for BioPharma

Reduce time to market and the cost of market expansion by improving innovation and efficiency in discovery research to deliver better candidates faster

Adopt the Power of Designed to Cure

With increasing operational costs and high development failure rates resulting in fewer, lesser quality candidates entering clinical phases, the pressure is on to deliver better results that can drive down costs while reducing time to market. Designed to Cure enables collaborative, knowledge-driven innovation, and predictive analytics along with virtual design to enable higher quality candidates to get to market faster.

Contact Sales Get a Quote

Success story

Merck's Predictive Sciences Program Reduces Attrition and Cycle Time

The Predictive Sciences Program at Merck is a comprehensive package of data access, aggregation, predictive modeling, and advanced analytics that will transform productivity and inform the research and development decision making processes. This capability will allow scientists to use enhanced judgment resulting in reduced attrition and cycle time and increased Merck research and development pipeline productivity

44 minutes 1

Included in Designed to Cure

Designed to Cure enables therapeutic delivery, the prediction of critical design and manufacturability characteristics and delivers an integrated, comprehensive and rational drug development approach through virtual design, collaboration and knowledge driven innovation.